Cambridge, MA · Founded 2020 · Privately Held (backing)
Developer of a light-activated biomaterial platform designed to bring innovation in ocular and regenerative therapies. GelMEDIX is based in Cambridge, MA and was founded in 2020. It was valued at $21 million at its seed round in Feb 2026, the last priced event on record. It has raised $30.7 million across 4 recorded rounds; the latest was a $747,000 seed round in Oct 2025.
PMV mark · valuation
$21.0M
Oct 2026
Priced at
its seed round
Feb 2026
Total raised
$30.7M
Last round
Seed Round
Oct 2025
Team — not yet on record
No current team members for GelMEDIX are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of GelMEDIX with a free account
·Watch GelMEDIX: the Monday email on marks, rounds and moves
